CM
ETNB

Caption Management’s 89bio ETNB Stock Holding History

Caption Management’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-196,300
Closed -$2.89M – 1716
2025
Q3 		$2.89M Buy
196,300
+81,899
+72% +$835K 0.02% 688
2025
Q2 		$1.12M Sell
114,401
-66,199
-37% -$548K 0.01% 901
2025
Q1 		$1.31M Sell
180,600
-85,762
-32% -$750K 0.01% 824
2024
Q4 		$2.08M Buy
266,362
+11,162
+4% +$91.9K 0.02% 676
2024
Q3 		$1.89M Hold
255,200
– – 0.03% 581
2024
Q2 		$2.04M Buy
255,200
+114,216
+81% +$1.02M 0.03% 470
2024
Q1 		$1.64M Sell
140,984
-119,016
-46% -$1.32M 0.02% 591
2023
Q4 		$2.9M Buy
260,000
+144,000
+124% +$1.32M 0.04% 503
2023
Q3 		$1.79M Buy
+116,000
New +$1.95M 0.03% 611
2023
Q2 		– Sell
-260,638
Closed -$3.97M – 1187
2023
Q1 		$3.97M Buy
+260,638
New +$3.4M 0.08% 281

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Caption Management's ETNB Position: Q4 2025 in Review

Caption Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 196,300 shares — an estimated $2.89M sold.

Caption Management first reported a position in ETNB in Q1 2023 and held it in 10 quarters. The position peaked at $3.97M in Q1 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Caption Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Caption Management sold 196,300 89bio shares in Q4 2025, an estimated $2.89M.
  • Caption Management first reported a position in 89bio in Q1 2023 and held it in 10 quarters.
  • Caption Management's 89bio position peaked at $3.97M in Q1 2023.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Caption Management's 13F filing for Q4 2025, filed 17 Feb 2026.